• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴基斯坦北部乳腺癌的形态学特征及HER-2/neu与预后标志物的关联

Morphological profile and association of HER-2/neu with prognostic markers in breast carcinoma in Northern Pakistan.

作者信息

Sharif Muhammad Ashraf, Mamoon Nadira, Mushtaq Sajid, Khadim Muhammad Tahir

机构信息

Department of Histopathology, Armed Forces Institute of Pathology, Rawalpindi.

出版信息

J Coll Physicians Surg Pak. 2009 Feb;19(2):99-103.

PMID:19208313
Abstract

OBJECTIVE

To determine the morphological profile and association of HER-2/neu expression with histological prognostic markers and hormonal receptor expression in female breast carcinoma in Northern Pakistan.

STUDY DESIGN

Cross-sectional, observational study.

PLACE AND DURATION OF STUDY

Department of Histopathology, Armed Forces Institute of Pathology, Rawalpindi, from January 2004 to May 2007.

METHODOLOGY

A total of 535 patients of primary operable female breast carcinoma with hormonal profile and biological status were included in the study. Patient's age, microscopic tumour size, tumour grade, lymph node status, Estrogen Receptor (ER), Progesterone Receptor (PR) and joint ER/PR status were evaluated and their association was determined with HER-2/neu expression using the x2 test for univariate analysis.

RESULTS

Out of 535 cases, there were 481 (89.9%) cases of infiltrating ductal carcinoma with mean age of 48 years and mean tumour size of 4.4 cm. Tumour grade II was seen in 68% cases and lymph node metastases were present in 65% cases. HER-2/neu expression was seen in 31% cases, while ER and PR expression was seen in 72.3% and 62.6% respectively. ER and PR showed inverse association with HER-2/neu while positive association was seen with lymph node metastases (p < 0.05). No association was seen between tumour size and tumour grade. Joint ER and PR expression also showed a higher number (73.5%) of HER-2/neu negative cases.

CONCLUSION

HER-2/neu, ER and PR expression is comparable to the West with inverse association with ER and PR and positive association with lymph node metastases. Since HER-2/neu expression is variable in carcinomas with different tumour characteristics, it is not possible to predict hormone receptor expression in all the cases.

摘要

目的

确定巴基斯坦北部女性乳腺癌中HER-2/neu表达的形态学特征及其与组织学预后标志物和激素受体表达的相关性。

研究设计

横断面观察性研究。

研究地点和时间

2004年1月至2007年5月,拉瓦尔品第武装部队病理研究所组织病理学系。

方法

本研究共纳入535例具有激素谱和生物学状态的原发性可手术女性乳腺癌患者。评估患者的年龄、显微镜下肿瘤大小、肿瘤分级、淋巴结状态、雌激素受体(ER)、孕激素受体(PR)及联合ER/PR状态,并使用x2检验进行单因素分析,确定它们与HER-2/neu表达的相关性。

结果

535例病例中,有481例(89.9%)为浸润性导管癌,平均年龄48岁,平均肿瘤大小4.4 cm。68%的病例为II级肿瘤,65%的病例有淋巴结转移。31%的病例可见HER-2/neu表达,而ER和PR表达分别见于

相似文献

1
Morphological profile and association of HER-2/neu with prognostic markers in breast carcinoma in Northern Pakistan.巴基斯坦北部乳腺癌的形态学特征及HER-2/neu与预后标志物的关联
J Coll Physicians Surg Pak. 2009 Feb;19(2):99-103.
2
Steroid hormone receptor association with prognostic markers in breast carcinoma in Northern Pakistan.巴基斯坦北部乳腺癌中类固醇激素受体与预后标志物的关联
J Coll Physicians Surg Pak. 2010 Mar;20(3):181-5.
3
Age related association of Her-2/neu with prognostic markers in female breast carcinoma.女性乳腺癌中Her-2/neu与预后标志物的年龄相关性
J Coll Physicians Surg Pak. 2010 Sep;20(9):590-4.
4
Frequency of HER-2/neu receptor positivity and its association with other features of breast cancer.HER-2/neu受体阳性的频率及其与乳腺癌其他特征的关联。
J Ayub Med Coll Abbottabad. 2008 Jul-Sep;20(3):23-6.
5
Correlation of her-2/neu gene amplification with other prognostic and predictive factors in female breast carcinoma.女性乳腺癌中her-2/neu基因扩增与其他预后及预测因素的相关性
Breast J. 2005 Jul-Aug;11(4):278-80. doi: 10.1111/j.1075-122x.2005.21463.x.
6
Her-2/neu gene overexpression in breast carcinoma and its association with clinicopathological characteristics of the disease.Her-2/neu基因在乳腺癌中的过表达及其与该疾病临床病理特征的关联。
J Coll Physicians Surg Pak. 2009 May;19(5):297-9.
7
Do we need HER-2/neu testing for all patients with primary breast carcinoma?对于所有原发性乳腺癌患者,我们都需要进行HER-2/neu检测吗?
Cancer. 2003 Dec 15;98(12):2547-53. doi: 10.1002/cncr.11828.
8
Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.乳腺导管癌中雌激素受体、孕激素受体及c-erbB2癌基因蛋白表达的改变
Cell Biol Int. 2008 Jun;32(6):698-707. doi: 10.1016/j.cellbi.2008.01.007. Epub 2008 Jan 25.
9
Association between tumour characteristics and HER-2/neu by immunohistochemistry in 1362 women with primary operable breast cancer.1362例原发性可手术乳腺癌女性患者中肿瘤特征与免疫组化检测HER-2/neu之间的关联
J Clin Pathol. 2005 Jun;58(6):611-6. doi: 10.1136/jcp.2004.022772.
10
Association between HER-2/neu and the progesterone receptor in oestrogen-dependent breast cancer is age-related.雌激素依赖性乳腺癌中HER-2/neu与孕激素受体之间的关联与年龄相关。
Breast Cancer Res Treat. 2005 May;91(1):81-7. doi: 10.1007/s10549-004-8235-8.

引用本文的文献

1
Molecular Classification of Breast Carcinoma in a Tertiary Hospital of India: the Recent Trends.印度一家三级医院乳腺癌的分子分类:最新趋势
Indian J Surg Oncol. 2023 Mar;14(1):176-180. doi: 10.1007/s13193-022-01647-y. Epub 2022 Sep 16.
2
Systematic review of breast cancer biology in developing countries (part 2): asian subcontinent and South East Asia.发展中国家乳腺癌生物学的系统评价(第 2 部分):亚洲次大陆和东南亚。
Cancers (Basel). 2011 May 13;3(2):2382-401. doi: 10.3390/cancers3022382.
3
Estrogen receptor, progesterone receptor, and Her 2 Neu positivity and its association with tumour characteristics and menopausal status in a breast cancer cohort from northern Pakistan.
巴基斯坦北部乳腺癌队列中雌激素受体、孕激素受体和人表皮生长因子受体2(Her 2 Neu)的阳性表达及其与肿瘤特征和绝经状态的关联
Ecancermedicalscience. 2012;6:283. doi: 10.3332/ecancer.2012.283. Epub 2012 Dec 11.